The global Integrin Alpha V market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Integrin Alpha V volume and value at global level, regional level and company level. From a global perspective, this report represents overall Integrin Alpha V market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Integrin Alpha V in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Integrin Alpha V manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Biogen Inc
BioMAS Ltd
Factor Therapeutics Ltd
MedImmune LLC
Merck & Co Inc
Merck KGaA
Morphic Therapeutic Inc
SciFluor Life Sciences LLC
Vascular Pharmaceuticals Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
MK-0429
C-16Y
264-RAD
AC-301
Others

Segment by Application
Metabolic Disorders
Ophthalmology
Respiratory
Infectious Disease
Others